Market cap of gene and cell therapy companies 2023
This statistic shows the market capitalization of select significant gene and cell therapy companies from several countries, as of March 31, 2023. The selection excludes large companies involved in cell and gene therapy. The market capitalization of Bluebird Bio, an oncology gene therapy company, stood at some 320 million U.S. dollars. Many of this smaller companies saw a decline in market capitalization over the last few years.